Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Shields

Showing results (271-280 of 413) with videos related to

Pageof 42
Sort By:
Antimicrobial Agents and Chemotherapy|February 26, 2014
Doripenem, gentamicin, and colistin, alone and in combinations, against gentamicin-susceptible, KPC-producing Klebsiella pneumoniae strains with various ompK36 genotypesCornelius J Clancy, Binghua Hao, Ryan K Shields, et al.
Antimicrobial Agents and Chemotherapy|July 4, 2012
The presence of an FKS mutation rather than MIC is an independent risk factor for failure of echinocandin therapy among patients with invasive candidiasis due to Candida glabrataRyan K Shields, M Hong Nguyen, Ellen G Press, et al.
The Journal of Antimicrobial Chemotherapy|June 4, 2024
Initial micafungin treatment does not improve outcomes compared to fluconazole treatment in immunocompromised and critically ill patients with candidaemiaDeborah A Theodore, Amrita D Henneman, Angela Loo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 29, 2020
Changing Epidemiology and Decreased Mortality Associated With Carbapenem-resistant Gram-negative Bacteria, 2000-2017Ahmed Babiker, Lloyd G Clarke, Melissa Saul, et al.
Journal of Ophthalmic Inflammation and Infection|July 17, 2025
Publisher Correction: Pharmacotherapy for non-infectious uveitis: spotlight on phase III clinical trials of locally injected or implanted therapeutics and systemic immunomodulatory drugsMelissa K Shields, Lisia Barros Ferreira, Syed B Ali, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 16, 2022
Evolution and Transmission of Cefiderocol-Resistant Acinetobacter baumannii During an Outbreak in the Burn Intensive Care UnitSteven M Smoke, Alison Brophy, Samuel Reveron, et al.
Journal of Ophthalmic Inflammation and Infection|June 5, 2025
Pharmacotherapy for non-infectious uveitis: spotlight on phase III clinical trials of locally injected or implanted therapeutics and systemic immunomodulatory drugsMelissa K Shields, Lisia Barros Ferreira, Syed B Ali, et al.
Archives of Physical Medicine and Rehabilitation|October 11, 2005
Bone mineral density after spinal cord injury: a reliable method for knee measurementRichard K Shields, Janet Schlechte, Shauna Dudley-Javoroski, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|December 14, 2004
Proprioceptive coordination of movement sequences in humansRichard K Shields, Sangeetha Madhavan, Keith R Cole, et al.
Plos One|April 29, 2016
Intra-Abdominal Candidiasis: The Importance of Early Source Control and Antifungal TreatmentPascalis Vergidis, Cornelius J Clancy, Ryan K Shields, et al.
Pageof 42

Showing results (271-280 of 413) with videos related to

Sort By:
Pageof 42
Antimicrobial Agents and Chemotherapy|February 26, 2014
Doripenem, gentamicin, and colistin, alone and in combinations, against gentamicin-susceptible, KPC-producing Klebsiella pneumoniae strains with various ompK36 genotypesCornelius J Clancy, Binghua Hao, Ryan K Shields, et al.
Antimicrobial Agents and Chemotherapy|July 4, 2012
The presence of an FKS mutation rather than MIC is an independent risk factor for failure of echinocandin therapy among patients with invasive candidiasis due to Candida glabrataRyan K Shields, M Hong Nguyen, Ellen G Press, et al.
The Journal of Antimicrobial Chemotherapy|June 4, 2024
Initial micafungin treatment does not improve outcomes compared to fluconazole treatment in immunocompromised and critically ill patients with candidaemiaDeborah A Theodore, Amrita D Henneman, Angela Loo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 29, 2020
Changing Epidemiology and Decreased Mortality Associated With Carbapenem-resistant Gram-negative Bacteria, 2000-2017Ahmed Babiker, Lloyd G Clarke, Melissa Saul, et al.
Journal of Ophthalmic Inflammation and Infection|July 17, 2025
Publisher Correction: Pharmacotherapy for non-infectious uveitis: spotlight on phase III clinical trials of locally injected or implanted therapeutics and systemic immunomodulatory drugsMelissa K Shields, Lisia Barros Ferreira, Syed B Ali, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 16, 2022
Evolution and Transmission of Cefiderocol-Resistant Acinetobacter baumannii During an Outbreak in the Burn Intensive Care UnitSteven M Smoke, Alison Brophy, Samuel Reveron, et al.
Journal of Ophthalmic Inflammation and Infection|June 5, 2025
Pharmacotherapy for non-infectious uveitis: spotlight on phase III clinical trials of locally injected or implanted therapeutics and systemic immunomodulatory drugsMelissa K Shields, Lisia Barros Ferreira, Syed B Ali, et al.
Archives of Physical Medicine and Rehabilitation|October 11, 2005
Bone mineral density after spinal cord injury: a reliable method for knee measurementRichard K Shields, Janet Schlechte, Shauna Dudley-Javoroski, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|December 14, 2004
Proprioceptive coordination of movement sequences in humansRichard K Shields, Sangeetha Madhavan, Keith R Cole, et al.
Plos One|April 29, 2016
Intra-Abdominal Candidiasis: The Importance of Early Source Control and Antifungal TreatmentPascalis Vergidis, Cornelius J Clancy, Ryan K Shields, et al.
Pageof 42